| Literature DB >> 34192573 |
Peter Taber1, Catherine J Staes2, Saifon Phengphoo2, Elisa Rocha3, Adria Lam4, Guilherme Del Fiol5, Saverio M Maviglia6, Roberto A Rocha6.
Abstract
BACKGROUND: Development and dissemination of public health (PH) guidance to healthcare organizations and the general public (e.g., businesses, schools, individuals) during emergencies like the COVID-19 pandemic is vital for policy, clinical, and public decision-making. Yet, the rapidly evolving nature of these events poses significant challenges for guidance development and dissemination strategies predicated on well-understood concepts and clearly defined access and distribution pathways. Taxonomies are an important but underutilized tool for guidance authoring, dissemination and updating in such dynamic scenarios.Entities:
Keywords: COVID-19; Content analysis; Indexing; Knowledge management; Public health guidance; Taxonomy
Mesh:
Year: 2021 PMID: 34192573 PMCID: PMC8236411 DOI: 10.1016/j.jbi.2021.103852
Source DB: PubMed Journal: J Biomed Inform ISSN: 1532-0464 Impact factor: 8.000
Fig. 1Phases and steps within the iterated sampling and classification workflow. Circles indicate the point at which the method is iterated; text in the circles specifies what (if any) changes to sampling strategy are to be made in the next iteration. The workflow was terminated when stakeholders and settings reached saturation for two iterations [1]Channels included FL, IL, MA, UT and CDC [2]Purposive sampling relies on analyst judgment to select samples that maximize variability; random sampling selects a proportion of samples from a corpus stratified by a priori categories. [3]Interrater reliability is measured using kappa statistics. 0.75 is considered a desirable kappa. [4]Thematic saturation refers to the degree of exhaustiveness with which the taxonomy captures concepts in sampled documents. Less than or equial to 5% change between iterations is considered acceptable.
Fig. 2Weekly average rate of new COVID-19 cases for Florida, Illinois, Massachusetts, and Utah. Y-axis is new cases/100 k individuals based on 2019 census data. Data drawn from JHU CSSE.[23].
Number of URLs and proportion of randomly sampled guidance documents identified for each state public health agency. Links to NIH and WHO are omitted because of their infrequency.
| FL | IL | MA | UT | ||
|---|---|---|---|---|---|
| # URLs identified in state PH websites | 54 | 216 | 581 | 229 | |
| # (%) URLs containing PH guidance | 31 (57%) | 110 (51%) | 319 (55%) | 74 (32%) | |
| Proportion of guidance documents by stakeholder | % Healthcare | 42 | 41 | 35 | 23 |
| % Non-healthcare | 23 | 31 | 44 | 20 | |
| % General public | 35 | 28 | 22 | 57 | |
| # External links to CDC | 105 | 108 | 62 | 51 | |
| # (%) CDC links containing guidance | 78 (74%) | 67 (62%) | 37 (60%) | 38 (75%) | |
| Proportion of guidance documents by stakeholder | % Healthcare | 31 | 34 | 32 | 32 |
| % Non-healthcare | 8 | 24 | 24 | 16 | |
| % General public | 62 | 42 | 43 | 53 | |
| # External links to NIH or WHO | 0 | 4 | 5 | 0 | |
Fig. 3Cumulative and percent change in total taxonomy branches across major iterations of guidance sampling from FL, IL, MA, UT and/or CDC.
Fig. 4Percent change in subunits of the taxonomy across major iterations. (Note: negative values indicate iterations where the taxonomy was revised to collapse concepts.)
Fig. 5Example branches of the preliminary taxonomy of pH guidance. Green represents the taxonomy’s three domains: stakeholder, setting and topic. Blue indicates intermediate categories. Gray indicates the terminal concepts for the represented branches. The number in brackets indicates the total number of branches encompassed by a level in the taxonomy. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Percentage of randomly sampled documents (n = 226) by stakeholder, setting and topic. (Note: a document may belong to multiple concepts within any taxonomic level; columns do not sum to 100%.)
| FL (n = 17) | IL (n = 34) | MA (n = 114) | UT (n = 21)_ | CDC (n = 40) | All (n = 226) | ||
|---|---|---|---|---|---|---|---|
| % | % | % | % | % | % | ||
| Settings | Healthcare | 12 | 44 | 35 | 29 | 28 | 33 |
| Non-healthcare | 47 | 32 | 56 | 62 | 35 | 49 | |
| Unassigned | 47 | 26 | 16 | 19 | 35 | 23 | |
| Stakeholders | General public | 76 | 65 | 49 | 81 | 65 | 59 |
| Healthcare | 29 | 38 | 33 | 38 | 40 | 35 | |
| Non-healthcare | 29 | 29 | 46 | 38 | 23 | 37 | |
| Topics | Risk management | 82 | 91 | 69 | 95 | 75 | 77 |
| Clinical presentation/diagnosis | 29 | 56 | 18 | 43 | 35 | 30 | |
| Reopening | 12 | 15 | 35 | 14 | 13 | 24 | |
| Economic dimensions | 6 | 9 | 26 | 19 | 8 | 18 | |
| Clinical disposition/treatment | 6 | 35 | 7 | 10 | 20 | 14 | |
| Resource management | 12 | 18 | 8 | 14 | 13 | 11 | |
| Mental health and wellness | 6 | 3 | 9 | 5 | 15 | 8 | |
| Discrimination/stigma/ethics | 0 | 12 | 1 | 0 | 8 | 4 | |
| Care coordination | 0 | 3 | 3 | 5 | 0 | 2 | |